Follow the Algernon Pharmaceuticals Inc. stock price and the full insider trade history of the company, a listed equity based in Canada. Shares are quoted on the CA market, under the oversight of SEDI. The latest transaction was disclosed on 2 August 2024 (16 - Acquisition or disposition under a prospectus exemption). Among the most active insiders: Moreau, Christopher. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Algernon Pharmaceuticals Inc. is a biopharmaceutical company focused on developing new treatments for serious diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.